+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Vascular Endothelial Growth Factor (VEGF) Inhibitors Market 2022 by Type, Sales Channel, Application, Regions, Company Share, Forecast to 2030

Publish Date: Mar 2024
Report ID:HC-1096
Base Year:2023
Report Format:PDF, Excel
Report Pages:197
Region:Global

Table of Content

  1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Scope and Market Estimation
      1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
      2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
    3. Market Segmentation
      1. Product Type of Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
      2. Route of Administration of Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
      3. Application of Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
      4. Region of Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market
  2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets
      3. Market Attractiveness Analysis
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Product Type
      2. By Route of Administration
      3. By Application
  4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Historic Trend Analysis (2017-2020)
  5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Estimates & Forecast Trend Analysis, by Product Type
    1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, by Product Type, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Avastin
    4. Tecentriq
    5. Cometriq
    6. Eylea
    7. Others
  6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Estimates & Forecast Trend Analysis, by Route of Administration
    1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, by Route of Administration, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oral
    4. Intravenous
  7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Estimates & Forecast Trend Analysis, by Application
    1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, by Application, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oncology
    4. Ophthalmology
    5. Others
  8. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis and Forecast, by Region
    1. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  9. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Forecast Trend Analysis
    1. North America Market Assessments & Key Findings
    2. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By Country
        1. U.S.
        2. Canada
        3. Mexico
  10. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Europe Market Assessments & Key Findings
    2. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  11. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Asia Pacific Market Assessments & Key Findings
    2. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  12. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Forecast Trend Analysis
    1. Middle East & Africa Market Assessments & Key Findings
    2. Middle East & Africa Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East & Africa
  13. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market: Estimates & Forecast Trend Analysis
    1. South America Market Assessments & Key Findings
    2. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Product Type
      2. By Route of Administration
      3. By Application
      4. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  14. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitors
    3. Manufacturing Process Analysis of Vascular Endothelial Growth Factor (VEGF) Inhibitors
    4. Industry Chain Structure of Vascular Endothelial Growth Factor (VEGF) Inhibitors
  15. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Distributors
    3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Customer
  16. Competition Landscape
    1. Key Manufacturers Vascular Endothelial Growth Factor (VEGF) Inhibitors Producing Area Distribution, Sales Area, Product Type
    2. Key Manufacturers Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  17. Company Profiles
    1. Pfizer
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    2. Amgen, Roche
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    3. Xbrane Biopharma AB
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    4. Regeneron Pharmaceuticals Inc.
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    5. F. Hoffmann-La Roche Ltd.
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    6. Novartis AG
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    7. Sanofi
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    8. Genentech Inc.
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    9. AstraZeneca plc
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    10. Bayer AG
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    11. Eli Lilly and Company
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    12. Allergan plc
      1. Company Information
      2. Vascular Endothelial Growth Factor (VEGF) Inhibitors Product Offered
      3. Vascular Endothelial Growth Factor (VEGF) Inhibitors Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
  18. Assumptions and Research Methodology
  19. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion

List of Tables

  1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Historic Analysis (US$ Mn), 2017-2021
  2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
  3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  7. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Region, 2017-2030
  8. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  9. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  10. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  11. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  12. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Country, 2017-2030
  13. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  14. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  15. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  16. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  17. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Country, 2017-2030
  18. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  19. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  20. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  21. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  22. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Country, 2017-2030
  23. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  24. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  25. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  26. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  27. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Country, 2017-2030
  28. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Absolute $ Opportunity
  29. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Product Type, 2017-2030
  30. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Route of Administration, 2017-2030
  31. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Application, 2017-2030
  32. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Analysis by Country, 2017-2030

List of Figures

  1. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Historic Y-o-Y Analysis (%), 2017-2021
  2. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Forecast Y-o-Y Analysis (%), 2022-2030
  3. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  4. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  5. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  6. Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Region, 2021 and 2030
  7. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  8. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  9. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  10. North America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Country, 2021 and 2030
  11. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  12. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  13. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  14. South America Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Country, 2021 and 2030
  15. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  16. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  17. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  18. Europe Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Country, 2021 and 2030
  19. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  20. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  21. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  22. Asia Pacific Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Country, 2021 and 2030
  23. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Product Type, 2021 and 2030
  24. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Route of Administration, 2021 and 2030
  25. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Application, 2021 and 2030
  26. MEA Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Share Analysis by Country, 2021 and 2030
    market statsville report image

    Want to Review Complete Market Research Report

    Request Sample
    $3150  $2450 save 23%
    $4950  $3850 save 25%
    $7680  $5100 save 30%
    Buy Chapters or Sections

    Avail customized purchase options to meet your exact research needs:

    • Buy sections of this report
    • Buy country level reports
    • Request for historical data
    • Request discounts available for Start-Ups & Universities

    Budget constrains? Get in touch with us for special pricing
    Request Discount

    Phone: +1 (888) 615 4898

    Email: sales@regionalresearchreports.com

    Chat with Us: Click here to start